Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT7ZK9C)

DTT Name	Tryptophan 5-hydroxylase (TPH)
Gene Name	TPH
DTT Type	Clinical trial target	[1]
BioChemical Class	Paired donor oxygen oxidoreductase
UniProt ID	NOUNIPROTAC
TTD ID	T45083

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LX-1031	DMZ2XAP	Irritable bowel syndrome	DD91.0	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome. IDrugs. 2010 Dec;13(12):921-8.